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volving several other kinases as well as small GTP
The cytokine tumor necrosis factor (TNF) a was binding proteins (For review see 1-3).
found to stimulate the p38 mitogen activated protein Recently, two homologues of p38 MAP kinase have
(MAP) kinase signalling cascade in human umbilical been identi®ed in human monocytes by the use of a
vein endothelial cells. TNFa increased the activity of class of pyridinyl imidazoles (4). These drugs inhibitthe p38 substrate MAP kinase-activated-protein (MAP- the production of interleukin-1b and tumor necrosisKAP) kinase 2 and the subsequent phosphorylation of
factor (TNF) by stimulated monocytes. The pyridinylthe small heat shock protein Hsp27 about two to three
imidazole SB203580 speci®cally inhibits p38 MAP ki-fold. This stimulation was blocked almost completely
nase (5), and the subsequent phosphorylation of itsby the speci®c p38 MAP kinase inhibitor SB203580.
physiological substrate MAP kinase-activated-protein-This inhibitor also suppressed the TNFa-induced sur-
kinase-2 (MAPKAP kinase-2). Activation of MAPKAPface expression of the endothelial adhesion molecule
kinase-2 leads to increased phosphorylation of thevascular cell adhesion molecule (VCAM)-1. In contrast,
small heat shock proteins (Hsp) Hsp25 and Hsp27 (6,7).inhibition of p38 MAP kinase had no effect on the stim-
TNFa has been demonstrated to stimulate MAP-ulated surface expression of the intercellular cell ad-
KAP-kinase 2 activity (8) and to increase the phosphor-hesion molecule (ICAM)-1. VCAM-1 mRNA accumula-
tion induced by TNFa was not affected by SB203580, ylation of small Hsp in mammalian cells (9). In endo-
suggesting that the p38 MAP kinase signalling cascade thelial cells TNFa induces the expression of vascular
regulates the endothelial expression of VCAM-1 at the cell adhesion molecule-1 (VCAM-1), and increases the
post-transcriptional level. q 1997 Academic Press expression of the intercellular cell adhesion molecule-
1 (ICAM-1). The biological functions of these adhesion
molecules are distinct. ICAM-1 binds leukocytes via
their b2 integrins and can therefore serve to recruit
both granulocytes and monocytes from the bloodstreamUnder conditions of cellular stress, such as heat
to sites of tissue injury, whereas VCAM-1 binds mono-shock, UV radiation and osmotic stimulation, as well
cytes and lymphocytes expressing the integrins a4b1as subsequent to cytokine treatment at least two
and a4b7 speci®cally supporting the recruitment ofmembers of the superfamily of mitogen-activated
chronic in¯ammatory cells (10,11). In this paper weprotein (MAP) kinases are rapidly activated. These
have investigated whether there is a direct connectionenzymes, which are distinct from the extra-cellularly
between the p38 MAP kinase cascade and the expres-regulated kinase (Erk)-1 and Erk2 stimulated by
sion of the endothelial adhesion molecules. By the usegrowth factors, are p38 MAP kinase/reactivating ki-
of the inhibitor SB203580 we demonstrate that the ex-nase (RK) and c-jun amino terminal kinase (JNK)/
pression of VCAM-1, but not ICAM-1, is likely regu-stress-activated protein (SAP) kinase. Like Erk1/2
lated by the p38 MAP kinase at the post-transcrip-these enzymes are activated through a cascade in-
tional level.
MATERIALS AND METHODS1 Corresponding author. Department of Biochemistry, Erasmus
University Rotterdam, P. O. Box 1738, 3000 DR Rotterdam, The Culture and FACS analysis of endothelial cells. Human umbilical
vein endothelial cells (HUVEC) were cultured as previously de-Netherlands. Fax: 31 10 4360615. E-mail: sluiter@bc1.fgg.eur.nl.
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scribed (12) in M199 (Flow Laboratories) supplemented with 10% Hsp27 phosphorylation. HUVEC were washed twice with phos-
phate-free modi®ed-Earles and incubated in the same medium con-newborn calf serum, 10% human serum kindly provided by the Red
Cross Bloodbank, Rotterdam, The Netherlands, endothelial cell taining 0.4 mCi/ml 32PO304 (Amersham) for 3 h. Thereafter, the cells
were stimulated, washed 3 times (150 mM NaCl, 20 mM Na3PO4,growth factor, 15 U/ml heparin, 50 U/ml penicillin, and 5 mg/ml strep-
tomycin, under 95% air/5% CO2. Con¯uent endothelial monolayers pH7.4, 0 7C) and Hsp27 phosphorylation was determined as de-
scribed by Cuenda et al. (5). Brie¯y, after solubilization of the cellswere treated as indicated in the legends, either in the presence or
absence of SB203580, which was the generous gift of SmithKline (lysis buffer, 10 minutes), the lysates were collected, cleared by cen-
trifugation and protein G-Sepharose-conjugated anti-Hsp27 antibod-Beecham, King of Prussia, USA. Cells were harvested and incubated
for 30 min at 47C with either monoclonal antibody clone IG11B1 ies (StressGen, Victoria, Canada) were added to the supernatants.
After 2 h of incubation at 0 7C, the beads were centrifuged, washed(Monosan, Uden, The Netherlands) directed against VCAM-1, or
clone MEM112 (Monosan) directed against ICAM-1, or control mouse 3 times with 1 ml lysis buffer containing 0.5 M NaCl and twice with
lysis buffer, resuspended in sample mix and subjected to SDS-PAGE.IgG1K. The second antibody was a ¯uorescein isothiocyanate conju-
gated rabbit anti-mouse Fab2 fragment (Sigma Chemical Corp). Radioactivity in the Hsp27 band was quantitated by phospho-im-
aging as described above.Membrane antigen expression was analysed by ¯uorescence acti-
vated cell sorting (FACS) as previously described (13), and is ex-
pressed as linear ¯uorescence intensity (F.I.).
RESULTS
Polymerase chain reaction. Total RNA was isolated from 106 HU-
VEC stimulated with TNFa (0 - 100 U/ml in complete M199) ac-
Stimulation of the p38 MAP Kinase Cascade bycording to the method of Chomszynski et al. (14). cDNA was produced
from 75 ng of each RNA extract by M-MLV reverse transcriptase TNFa in Endothelial Cells
(Promega) according instructions provided by the manufacturer. Spe-
To study whether the p38 MAP kinase cascade isci®c oligonucleotide primers (forward primer:5*-CGGGATCCATCC-
ACAAAGCTGCAAGAA-3 *, and reverse primer:5*-GCGAATTCG- linked to the TNFa stimulated expression of endothe-
CCACCACTCATCTCGATTT-3 *), yielding a polymerase chain reac- lial leukocyte adhesion molecules, we ®rst analysed the
tion (PCR) product of 563 base pairs, were synthesized by Eurogentec process of activation of p38 MAP kinase by TNFa inaccording to the VCAM-1 cDNA sequence reported by Cybulsky et
HUVEC. For that reason we stimulated these cells byal (15). cDNA was ampli®ed by 30 cycles with Goldstar DNA polymer-
TNFa and measured the activity of the p38 MAP ki-ase (Eurogentec) in a Perkin Elmer thermocycler 480 in a touch
down protocol, in which the annealing temperature was gradually nase target MAPKAP kinase-2 as well as the phosphor-
decreased from 72 7C to 53 7C. Homology of PCR product with the ylation of the MAPKAP kinase-2 target, the small
VCAM-1 cDNA was con®rmed by sequence analysis. stress protein Hsp27, in these cells (Fig. 1). As demon-
Northern blot analysis. Total cellular RNA (20 mg) was size-frac- strated in Fig. 1a TNFa stimulates MAPKAP kinase-
tioned using 1.2 % agarose formaldehyde gel in the presence of 1
2 activity to about three fold in HUVEC. Furthermore,mg ethidium bromide. The RNA was transferred onto Hybond and
an increased phosphorylation of endogenous Hsp27 incovalently linked by ultraviolet irradiation. Hybridizations were per-
formed at 42 7C for 18 h in 50% deionized formamide, 1 M NaCl, 2.5 these cells after TNFa-treatment could be observed
% dextran sulfate, 35 mg/ml denatured ®sh DNA in 20% P buffer (1% (Fig. 1b). The activation and phosphorylation of these
BSA, 1% polyvinylpyrrolidone, 1% Ficoll, 250 mM Tris-HCl, 0.5% downstream targets of p38 MAP kinase in response toNa-pyrophosphate, 5% SDS). The PCR product (approximately 50
TNFa indicate a TNFa-induced activation of p38 MAPng cDNA) was radiolabeled with [a-32P]dCTP ({50 mCi per hybridiza-
kinase. To examine this further, we used the speci®ction)by the use of a labelling kit (Amersham). After hybridization,
®lters were washed with a ®nal stringency of 2 1 SSC (1 1  150 p38 MAP kinase inhibitor SB203580. After preincuba-
mM NaCl, 15 mM Na citrate), 0.1% SDS at room temperature. Auto- tion of the HUVEC with this inhibitor the TNFa-in-
radiograms were quanti®ed by phospho-imaging (Molecular Imaging duced stimulation of MAPKAP kinase-2 activity (dataSystem GS-363, Biorad).
not shown) and the phosphorylation of endogenous
MAPKAP kinase 2 activity assay. HUVEC were stimulated as
Hsp27 could be almost completely blocked (Fig. 1b).indicated in the legends and washed three times with ice-cold phos-
This ®nding con®rms the notion that TNFa activatesphate buffered saline (PBS). Thereafter, cells were scraped, sedi-
mented and stored at 080 7C prior to the assay. The pellet was re- the p38 MAP kinase cascade in HUVEC.
dissolved in lysis buffer (0.27 M sucrose, 50 mM NaF, 20 mM Tris-
acetate, 10 mM b-glycerophosphate, 5 mM pyrophosphate, 1 mM Role of p38 MAP Kinase in the Expression ofEGTA, 1 mM Na3VO4, 0.1 mM EDTA, 1 mM benzamidine, 0.2 mM
Endothelial Cell Adhesion Moleculesphenylmethane-sulfonyl¯uoride, 2 mg/ml leupeptin, 1% Triton X-100
and 0.1% b-mercaptoethanol, pH7.0) and incubated for 15 minutes
In parallel to the stimulation of the p38 MAP kinaseat 0 7C. Lysates were cleared by centrifugation and the supernatants
cascade, TNFa also stimulates the expression of thewere incubated with an anti-MAPKAP kinase 2 antiserum over night
prior to addition of protein A-Sepharose. One hour later the immuno- endothelial leukocyte adhesion molecules VCAM-1 and
precipitates were washed three times with TBS (20 mM Tris-HCl, ICAM-1. At 6 h after stimulation of HUVEC with TNFa
0.154 M NaCl, pH7.5) containing 50 mM NaF, 1 mM Na3VO4 and an increased expression of both VCAM-1 and ICAM-11% Triton X-100 and ®nally resuspended in a buffer consisting of 50
can be detected by FACS analysis (Fig. 2). To study themM Na-b-glycerophosphate, 4 mM Mg-acetate, 1 mM EDTA, 20 mM
involvement of the p38 MAPK cascade in the regulationH7 (Calbiochem), 20 mM HA1077 (Calbiochem), 2.5 mM protein ki-
nase A inhibitor (Gibco), and 0.4 mg/ml Hsp25. The reaction was of VCAM-1 and ICAM-1 expression, we preincubated
started by the addition of ATP (0.1 mM ATP containing 2 mCi g- HUVEC with the p38 MAP kinase inhibitor SB203580.32P-ATP) and terminated 10 minutes later by the addition of SDS- This inhibition of the p38 MAP kinase signi®cantly re-stopmix. Samples were subjected to SDS-PAGE and radioactivity in
duced the expression of VCAM-1 at the surface of thethe Hsp25-band was quantitated by phospho-imaging as described
above. cell (Fig. 2a). In contrast, ICAM-1 expression was not
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SB203580 did not affect the accumulation of VCAM-1
mRNA, which gradually increased after 1 to 6 h of
stimulation with TNFa.
DISCUSSION
The recently identi®ed p38 MAP kinase signalling
cascade is activated under conditions of cellular stress,
such as heat shock, hyperosmotic stimulation and after
treatment with cytokines (1-3). In the present report
we showed that the p38 MAP kinase pathway is func-
tional in HUVEC, since (i) TNFa stimulates the activ-
ity of MAPKAP kinase-2 and the subsequent phosphor-
FIG. 1. Activation of MAPKAP kinase 2 activity in endothelial
cells stimulated with 100 U/ml TNFa. After 10 min of stimulation
cells were lysed, and MAPKAP kinase 2 was immuno-precipitated.
Enzymatic activity was assessed by Hsp25 phosphorylation in vitro.
Data are presented as mean{ sem, n3. (b) TNFa stimulated Hsp27
phosphorylation in endothelial cells. 32PO304 pre-loaded cells were
treated with or without 100 U/ml TNFa for 10 min, in the absence
grey bars) or presence (hatched bars) of 20 mM SB203580. Hsp27
was immuno-precipitated and subjected to SDS-PAGE. Radioactivity
in the Hsp27 band was quantitated by phospho-imaging. The results
are representative of two independent experiments.
affected by inhibition of the p38 MAP kinase in endo-
thelial cells (Fig. 2b).
Evidence for Post-transcriptional Regulation of
VCAM-1 Surface Expression by the p38 MAP
Kinase Cascade
FIG. 2. Effect of SB203580 on the TNFa-induced expression of
To understand the mechanism by which the p38 VCAM-1 (a) and ICAM-1 (b). Con¯uent monolayers of endothelial
cells were pretreated with 20 or 50 mM SB203580 for 30 min, andMAP kinase cascade regulates the VCAM-1 expression
subsequently stimulated with 100 U/ml TNFa for 6 h also in thein endothelial cells we determined the VCAM-1 mRNA-
presence of SB203580. The expression of VCAM-1 and ICAM-1 waslevel in TNFa stimulated cells in the presence and ab- assessed by FACS analysis. The results are expressed as ¯uorescence
sence of the p38 MAP kinase inhibitor SB203580. From intensities (mean { sem, n305). Asterisks indicate a signi®cant
difference from the untreated control. (Student's t-test, p0.05).the results presented in Fig. 3 it can be seen that
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regulation of VCAM-1 protein expression requires ei-
ther a sustained activation of this signalling cascade
(18), or the relatively stable phosphorylation of a sub-
strate of the p38 MAP kinase pathway. In this respect
it is relevant to indicate that TNF-action in ®broblasts
has been shown to involve the inhibition of several pro-
tein phosphatases, which would increase the half-life
of a putative phosphorylated intermediate (19). It is of
note that the complete inhibition of the p38 MAP ki-
nase could only partially decrease VCAM-1 protein ex-
pression. This indicates that p38 MAP kinase regulates
only part of this post-transcriptional control and that
other signalling cascades contribute as well.
The transcriptional regulation of VCAM-1 expres-
sion has been studied quite extensively and is likely to
involve the assembly of a unique transcription activa-
tion complex consisting of the inducible transcription
factors NFkB, IRF-1 and constitutive transcription fac-FIG. 3. Time course of the TNFa-induced expression of VCAM-
tor Sp-1 (20). However, in the present study we demon-1 mRNA. After 30 min pretreatment with 20 mM SB203580 or vehicle
endothelial cells were stimulated with 100 U/ml TNFa in the pres- strate for the ®rst time that VCAM-1 protein expres-
ence (hatched bars) or absence (grey bars) of SB203580. Total RNA sion by TNFa-stimulated endothelial cells is also regu-
was isolated and size-fractioned by denaturing 1.2 % agarose-formal- lated at the post-transcriptional level. ICAM-1dehyde gel electrophoresis, transferred to nitrocellulose, and hybrid-
expression on the other hand does not seem to dependized to 32P-labeled human VCAM-1-speci®c cDNA (inset). Data are
on p38 MAP kinase activity.representative of three indepent experiments.
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